BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 29074590)

  • 1. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of angiotensin type 2 receptor prevents endothelial nitric oxide synthase glutathionylation and nitration in ischaemic abductor muscle of diabetic mice.
    Robillard S; Mercier C; Breton V; Paquin-Veillette J; Guay A; Lizotte F; Geraldes P
    Diab Vasc Dis Res; 2020; 17(1):1479164119883978. PubMed ID: 31726870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Impaired Ischemia-Induced PDGF (Platelet-Derived Growth Factor) Signaling Actions and Vessel Formation Through the Activation of Scr Homology 2-Containing Phosphatase-1.
    Mercier C; Brazeau T; Lamoureux J; Boisvert E; Robillard S; Breton V; Paré M; Guay A; Lizotte F; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2469-2482. PubMed ID: 34320834
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb.
    Croteau L; Mercier C; Fafard-Couture É; Nadeau A; Robillard S; Breton V; Guay A; Lizotte F; Despatis MA; Geraldes P
    Diab Vasc Dis Res; 2021; 18(2):1479164121999033. PubMed ID: 33722087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vascular endothelial growth factor treatment induces blood flow recovery through vascular remodeling in high-fat diet induced diabetic mice.
    Xiao L; Yan K; Yang Y; Chen N; Li Y; Deng X; Wang L; Liu Y; Mu L; Li R; Luo M; Ren M; Wu J
    Microvasc Res; 2016 May; 105():70-6. PubMed ID: 26808210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
    Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
    J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
    Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role of reactive oxygen species-activated Trp melastatin channel-2 in mediating angiogenesis and postischemic neovascularization.
    Mittal M; Urao N; Hecquet CM; Zhang M; Sudhahar V; Gao XP; Komarova Y; Ushio-Fukai M; Malik AB
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):877-87. PubMed ID: 25675998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.
    Clayton JA; Chalothorn D; Faber JE
    Circ Res; 2008 Oct; 103(9):1027-36. PubMed ID: 18802023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Diallyl Trisulfide on Ischemic Tissue Injury and Revascularization in a Diabetic Mouse Model.
    Yang HB; Liu HM; Yan JC; Lu ZY
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):367-374. PubMed ID: 29642134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2.
    Park C; Lee TJ; Bhang SH; Liu F; Nakamura R; Oladipupo SS; Pitha-Rowe I; Capoccia B; Choi HS; Kim TM; Urao N; Ushio-Fukai M; Lee DJ; Miyoshi H; Kim BS; Lim DS; Apte RS; Ornitz DM; Choi K
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):86-96. PubMed ID: 26586661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.